Molecular Adsorbent Recirculating System (MARS) for Patients With Cirrhosis and Hepatic Encephalopathy

This study has been completed.
Sponsor:
Collaborator:
Sponsor of study was Teraklin, AG and Gambro, Inc.
Information provided by (Responsible Party):
Tarek Hassanein, SCTI Research Foundation
ClinicalTrials.gov Identifier:
NCT00287235
First received: February 2, 2006
Last updated: June 11, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2004
  Estimated Primary Completion Date: No date given
Publications:
Hassanein T, Tofteng F, Brown R, Mc Guire B, Lynch P, Mehta R, Larsen F, Gornbein J, Stange J, Blei A. Efficacy of Albumin Dialysis (MARS) in Patients with Cirrhosis and Advanced Grades of Hepatic Encephalopathy: A Prospective, Controlled, Randomized Multicenter Trial. Hepatology 2004;40:726A.